In 2008, a new human tumour virus, designated Merkel cell polyomavirus (MCPyV), was reported in Merkel cell carcinoma (MCC), which is a neuroendocrine carcinoma of the skin . Subsequent studies showed that MCPyV DNA was present in 25-90 % of MCCs worldwide (Becker et al., 2009; Chun et al., 2013; Feng et al., 2008; Foulongne et al., 2008; Garneski et al., 2009; Kassem et al., 2008; Katano et al., 2009; Kuwamoto et al., 2011; Nakajima et al., 2009) . Recent studies have also demonstrated the existence of MCPyV DNA in a variety of cancers (Pantulu et al., 2010; Spurgeon & Lambert, 2013; Wieland & Kreuter, 2011) . The prevalence rate of MCPyV in malignancies other than MCC differs, according to research groups from different regions. Thus, evidence has accumulated regarding the diverse geographical distribution of MCPyV, whereas information on the genetic variability of this virus in different populations remains scarce.
The present study investigated whether MCPyV isolates derived from tumours in Caucasians and Asians are genetically diverse in various backgrounds. First, we recently detected MCPyV DNA in cutaneous squamous cell carcinoma (SCC), cervical cancer, chronic lymphocytic leukaemia and non-small cell lung cancer in Japanese patients (Hashida et al., 2013a, b; Imajoh et al., 2012a Imajoh et al., , 2012b Imajoh et al., , 2013 Murakami et al., 2011) , and found that the sequences of the large T-antigen (LT) and viral protein 1 (VP1) genes were different from reference sequences of the MCPyV MCC350 isolate derived from a North American IP: 54.70.40.11
On: Sun, 13 Jan 2019 10:25:47 MCC (GenBank accession no. EU375803). Recently, Hattori et al. (2013) reported that one partial LT sequence (designated NU3) derived from Japanese MCC was genetically distinct from Caucasian strains. However, these results were based on sequence analyses of small gene segments, so studies of full-length gene sequences are needed to achieve a better understanding of the phylogenetic relationships between the two different populations. Secondly, most of the available MCPyV sequences were obtained from individuals living in Europe, or with European ancestry, whereas very few virus gene sequences are available from other geographical areas, especially Asia. Thus, full-length gene sequence data are required from the Asian population to facilitate a global phylogenetic analysis. To the best of our knowledge, only two groups have reported phylogenetic analyses of MCPyV using the full-length LT gene and complete viral sequences. Schowalter et al. (2010) raised the possibility that different MCPyV strains may be prevalent in Asia. However, their study sampled a small group of healthy individuals residing in the USA, and only three MCPyV genomes were isolated from skin swabs of three healthy individuals born in Asia: strains 10b (GenBank accession no. HM011540), 13a (HM011543) and 16b (HM011548). Martel-Jantin et al. (2012) also demonstrated the presence of two main clades and tentatively proposed classifying the two clades into Caucasian and Asian clades (designated C and A clades, respectively). However, no sequences have been reported for the full-length LT and VP1 genes derived from tumour specimens other than MCC, with the exception of the TKS strain (GenBank accession no. FJ464337), which originated from a Kaposi sarcoma in a Japanese patient (Katano et al., 2009) . In the present study, therefore, we conducted the first phylogenetic analyses of MCPyV strains derived from various tumours in the Asian population using the fulllength LT and VP1 gene sequences, and compared them with those of Caucasian strains.
Our samples comprised 12 Japanese MCPyV strains obtained from tumour tissues, which comprised seven MCCs (designated MCC-JT7, MCC-JT17, MCC-JK8, MCC-JK16, MCC-JK19, MCC-JK24 and MCC-JR3), four non-small cell lung cancers (LC-JK1, LC-JK17, LC-JK29 and LC-JK35) and one cutaneous SCC (SCC-JK5). The full-length MCPyV LT (nt 196-3080) and VP1 (nt 3156-4427) genes were successfully amplified from these samples by simple PCR using different combinations of the six and three primer pair sets listed in Table S1 (available in JGV Online), respectively, with the exception of LC-JK17 in which the entire VP1 sequence could not be obtained. DNA was isolated from surgically resected frozen tumour samples using a DNeasy Blood and Tissue kit (Qiagen), or from formalin-fixed paraffin-embedded resection samples using a WaxFree DNA kit (TrimGen). PCRs were conducted using 200 ng DNA with AmpliTaq Gold 360 Master Mix (Life Technologies) and 0.4 mM each primer in a total reaction volume of 50 ml. The reaction conditions were denaturation at 95 u C for 10 min, followed by 40 cycles of 95 u C for 30 s, 50-60 u C (depending on the primer set) for 30 s and 72 u C for 30 s, with a final extension for 7 min at 72 u C. The PCR products were purified using a High Pure PCR Product Purification kit (Roche Diagnostics) and sequenced directly with an ABI Prism BigDye Terminator v1.1 Cycle Sequencing kit (Life Technologies). The sequenced products were analysed using a model 3130 Genetic Analyzer (Applied Biosystems). The nucleotide sequences were edited using BioEdit (Ibis Biosciences). This study was approved by the Ethics Committee of Kochi Medical School, Kochi University.
To analyse the phylogenetic relationships among the strains isolated from Asia (including Japan), Europe and North America, we first used the maximum-likelihood method. The nucleotide sequences were aligned using CLUSTAL W (Thompson et al., 1994) . The best-fit substitution models used for phylogenetic analyses of the nucleotide sequences were selected with jModelTest and ProtTest, respectively (Abascal et al., 2005; Posada, 2008) . The maximumlikelihood phylogenetic trees were then inferred for the selected models using PhyML v3.0 (Guindon et al., 2010) . The bootstrap values were based on 1000 replicates for all trees. Phylogenetic trees were also constructed using the neighbour-joining method implemented in CLUSTAL W (Saitou & Nei, 1987) .
First, phylogenetic studies were performed using 82 complete sequences of the MCPyV LT gene, comprising our 12 Japanese tumour-derived sequences and four previously reported sequences derived from individuals born in Asia (strains 10b, 13a, 16b and TKS) (Katano et al., 2009; Schowalter et al., 2010) , and 66 Caucasian strains retrieved from GenBank in August 2013. According to the phylogenetic tree (Fig. 1a) , these sequences could be classified into two main clades, which we provisionally designated LT-A (Asian) and LT-C (Caucasian). All of the strains obtained in this study and the two available strains (16b and TKS) belonged to the LT-A clade. The LT-C clade included all of the Caucasian strains, with the exception of strains 25b (GenBank accession no. HM011552) and 322 (FJ173811). The strains 10b, 25b and 322 seemed to form a paraphyletic group (unclassified), close to but distinct from the LT-A clade. Strain 13a was included in the LT-C clade. The overall branching pattern of the LT gene phylogenetic tree generated by the neighbour-joining method was very similar to that obtained using the maximum-likelihood method (Fig. 1b) . Thus, these phylogenetic results were confirmed with two methods.
We investigated genetic variability and mutations in our samples. Four of the 12 complete sequences of the full-length LT gene obtained in this study contained different mutations that produced a truncated form (due to the presence of stop codons) of the LT protein, as observed in tumour-derived MCPyV isolates (Fig. 2 ). There were single-nucleotide substitutions in three cases (MCC-JT7, MCC-JT17 and MCC-JK8) and a frameshift mutation due to a nucleotide deletion in one case (MCC-JK16), all of which Journal of General Virology 95 Analysis of full-length MCPyV LT and VP1 genes generated stop codons. It is noteworthy that all of the Japanese strains obtained in this study had common mutations (GAA at nt 2210, CAT at nt 2277 and TAC at nt 2720). Such mutations were also found in strains TKS and 16b, but they were not observed in Caucasian strains. There were also mutations specific to both the LT-A and unclassified (strains 10b, 25b and 322) clades (CAT at nt 1865, CAT at nt 2303 and TAA at nt 2489). These mutations may form the characteristic phylogenetic features of the LT gene.
To determine whether the phylogenetic pattern observed with the complete LT sequences could be reproduced using other gene-specific data, we constructed trees based on 58 complete VP1 sequences, comprising 11 of our Japanese tumour-derived sequences and the four sequences derived from individuals born in Asia described above, and 43 Caucasian strain sequences retrieved from GenBank. The phylogenetic tree produced also indicated the existence of two major clades, which we designated VP-A (Asian) and VP-C (Caucasian) (Fig. 3a) . All of our Japanese isolates, as well as TKS and 16b, were grouped in the VP-A clade, whereas VP-C contained all of the Caucasian strains, with the exception of strain 25b. In agreement with the results obtained using the LT gene sequences, strains 10b and 25b formed an unclassified paraphyletic group. The VP1 gene phylogenetic tree constructed using the neighbour-joining method also had a similar pattern to that obtained with the maximum-likelihood method (Fig. 3b) .
In the present study, we showed that the MCPyV isolates derived from Japanese patients grouped within one clade, which was clearly distinct from a clade that contained isolates from Europe and North America. There was very low genetic divergence among the Caucasian isolates, whereas strain 10b isolated from an individual born in Asia formed a paraphyletic group, and strain 13a unexpectedly belonged to the Caucasian clade. These findings suggest that MCPyV genotypes vary in Europe and Asia, and that subgenotypes may be prevalent in Asia. In the current study, we tentatively proposed an unclassified paraphyletic group for the different origin of the isolates from healthy individuals residing in the USA (strains 25b and 322) and from an individual born in Asia (strain 10b (Dalianis & Hirsch, 2013; Moens et al., 2011) . Therefore, it would be useful to know whether the tumour-derived MCPyV strains are distinct from the WT strains that circulate in healthy individuals, and whether particular MCPyV genotypes predispose virus-infected subjects to the development of malignancies. All of the phylogenetic trees (Figs 1 and 3) showed that our tumour-derived MCPyV strains, as well as strains TKS and 16b, comprised a single cluster. Schowalter et al. (2010) reported that strain 16b shares high similarity with the tumour-derived TKS and differs by only three nucleotides in the entire 5.4 kb MCPyV genome. Thus, strain 16b may represent a variant WT strain. At present, we do not know whether our data indicate the presence of Asian genotypes that preferentially lead to cancers or merely the presence of Asia-related topotypes. Large-scale comparisons of the genotypes of viruses isolated from healthy subjects and from various tumour tissues with different geographical origins will be required to elucidate the possible links between MCPyV genotypes and cancer development.
In summary, we obtained phylogenetic evidence for the genetic divergence of MCPyV between Asians and Caucasians. The present findings also highlight the importance of conducting phylogenetic analyses of this virus on a global scale, which might provide insights into human population migrations, particularly when combined with the worldwide sequence divergence patterns demonstrated in other human polyomaviruses such as JC and BK viruses.
